{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:09:52Z","timestamp":1787972992073,"version":"build-2784847793"},"reference-count":80,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T00:00:00Z","timestamp":1768694400000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cell Biochemistry &amp;amp; Function"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Breast cancer continues to be the most commonly diagnosed cancer among women worldwide, with estrogen receptor\u2010positive (ER\u2009+) types making up the largest portion. At the heart of this subtype is the estrogen signaling pathway, especially the estrogen receptor alpha (ER\u03b1), which plays a major role in the development, growth, and response to these cancers. This review takes a close look at the structure and function of estrogen receptors and how they influence cancer progression. We explore current treatment strategies\u2014including well\u2010known drugs such as Tamoxifen and Fulvestrant, as well as aromatase inhibitors\u2014and explain how these therapies work and why resistance sometimes develops. This review also dives into newer, more targeted options, such as HER2 inhibitors, CDK4\/6 blockers, and drugs that interfere with the PI3K\/AKT\/mTOR pathway. These treatments are changing the game for many patients. In addition, the review highlights exciting progress in drug design, showing how researchers are improving the precision and effectiveness of cancer medications through innovations in medicinal chemistry. Antibody\u2010drug conjugates (ADCs) are being developed to deliver powerful drugs directly to cancer cells with fewer side effects. This article also looks at emerging approaches, like oral estrogen receptor degraders (SERDs), combination therapies, and precision medicine techniques that tailor treatment based on each patient's unique genetic profile. Altogether, these developments represent a major step forward in our understanding and treatment of ER+ breast cancer.<\/jats:p>","DOI":"10.1002\/cbf.70166","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:34:36Z","timestamp":1768808076000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting Estrogen Pathways in Breast Cancer: A Review of Current Therapies and Emerging Strategies"],"prefix":"10.1002","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1025-9027","authenticated-orcid":false,"given":"Maitri","family":"Dabhi","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, SSR College of Pharmacy Savitribai Phule Pune University UT of Dadra and Nagar Haveli &amp; Daman and Diu Silvassa India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5847-4370","authenticated-orcid":false,"given":"Ishvarchandra","family":"Parmar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, SSR College of Pharmacy Savitribai Phule Pune University UT of Dadra and Nagar Haveli &amp; Daman and Diu Silvassa India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrakant","family":"Bonde","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, SSR College of Pharmacy Savitribai Phule Pune University UT of Dadra and Nagar Haveli &amp; Daman and Diu Silvassa India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,1,18]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33588"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2024.106639"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13050723"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00758-0"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2024.106526"},{"issue":"1","key":"e_1_2_11_7_1","first-page":"1","article-title":"Breast Cancers With Intermediate Estrogen Receptor Expression: Characteristics, Prognosis and Treatment","volume":"24","author":"Voutsadakis I. A.","year":"2024","journal-title":"Clinical Breast Cancer"},{"issue":"3","key":"e_1_2_11_8_1","first-page":"1901","article-title":"A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer","volume":"24","author":"Clusan L.","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-14-0092"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20211033"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986708783503168"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00045.2009"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng2006"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2012.11.001"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/812540"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apcsb.2019.01.001"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12006"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.839005"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026615666150413154841"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0031"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2021.148520"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1385577"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2015.05.009"},{"issue":"11","key":"e_1_2_11_26_1","article-title":"A Review on the Use of Letrozole in Female and Male Infertility","volume":"14","author":"Pajai S.","year":"2022","journal-title":"Cureus"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-0341"},{"issue":"2","key":"e_1_2_11_28_1","first-page":"1234","article-title":"Antibody\u2010Drug Conjugates for Breast Cancer Treatment: Emerging Agents, Targets and Future Directions","volume":"24","author":"Yang T.","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"e_1_2_11_29_1","article-title":"Enhertu (Fam\u2010Trastuzumab\u2010Deruxtecan\u2010nxki) \u2013 Revolutionizing Treatment Paradigm for HER2\u2010Low Breast Cancer","volume":"82","author":"Siddiqui T.","year":"2022","journal-title":"Annals of medicine and surgery (2012)"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-1040"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1212986"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107059"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.03.006"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01552-2"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37297"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02293-z"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2018.12.27"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-10-0076"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112845"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2015.02.011"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-023-01413-5"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30116-5"},{"issue":"6","key":"e_1_2_11_43_1","first-page":"1234","article-title":"Efficacy and Safety of Trastuzumab Combined With Pertuzumab for Human Epidermal Growth Factor Receptor\u20102\u2010Positive Breast Cancer: A Meta\u2010Analysis of Randomized Controlled Trials","volume":"48","author":"Gao Q.","year":"2023","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.894861"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.03.012"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1838485"},{"issue":"1","key":"e_1_2_11_47_1","first-page":"102345","article-title":"An Overview of the Safety Profile and Clinical Impact of CDK4\/6 Inhibitors in Breast Cancer: A Systematic Review of Randomized Phase Ii and III Clinical Trials","volume":"109","author":"Stanciu I. M.","year":"2023","journal-title":"Cancer Treatment Reviews"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102086"},{"key":"e_1_2_11_49_1","unstructured":"Capivasertib. PubChem Compound Database [Internet]. Bethesda (MD): National Library of Medicine (US); [cited 2025 May 2]. Available from:https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Capivasertib."},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1177\/10600280241241531"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.7107"},{"key":"e_1_2_11_52_1","unstructured":"Alpelisib (CID 56649450). PubChem Compound Database [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); cited 2025 May 2. Available from:https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/56649450."},{"issue":"1","key":"e_1_2_11_53_1","first-page":"11","article-title":"Antibody\u2010Drug Conjugates in Breast Cancer Treatment: Resistance Mechanisms and the Role of Therapeutic Sequencing","volume":"8","author":"Larose \u00c9. A.","year":"2025","journal-title":"Cancer Drug Resistance (Alhambra, Calif.)"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00947-7"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1159\/000521499"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01397-y"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01397-y"},{"issue":"1","key":"e_1_2_11_58_1","first-page":"11","article-title":"Antibody\u2010Drug Conjugates in Breast Cancer Treatment: Resistance Mechanisms and the Role of Therapeutic Sequencing","volume":"8","author":"Larose \u00c9. A.","year":"2025","journal-title":"Cancer Drug Resistance (Alhambra, Calif.)"},{"issue":"1","key":"e_1_2_11_59_1","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221113694","article-title":"Next\u2010Generation Selective Estrogen Receptor Degraders and Other Novel Endocrine Therapies for Management of Metastatic Hormone Receptor\u2010Positive Breast Cancer: Current and Emerging Role","volume":"14","author":"Lloyd M. R.","year":"2022","journal-title":"Therapeutic Advances in Medical Oncology"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102432"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00387-5"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2025.1590593"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.2174\/2589977512999200821170221"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112689"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400267"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1039\/D4MD00961D"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2022.106154"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-3465"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01572"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-025-01137-5"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1039\/D4MD00961D"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-3465"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102432"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.115219"},{"key":"e_1_2_11_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105379"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1039\/D4OB01238K"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1110881"},{"key":"e_1_2_11_78_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040857"},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1419468"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28279"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2024.2776"}],"container-title":["Cell Biochemistry and Function"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cbf.70166","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cbf.70166","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cbf.70166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T04:51:23Z","timestamp":1769662283000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/cbf.70166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1002\/cbf.70166"],"URL":"https:\/\/doi.org\/10.1002\/cbf.70166","archive":["Portico"],"relation":{},"ISSN":["0263-6484","1099-0844"],"issn-type":[{"value":"0263-6484","type":"print"},{"value":"1099-0844","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-10-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70166"}}